Patients with hypocarnitinemia at timepoint 2 showed a significant percent seizure increase while seizures continued to decrease in the normal carnitine group
This is the first clinical trial of semaglutide for MASLD in people with HIV
This beneficial effect is, at least in part, due to the activation of the MET-AKT/GSK-3 signaling pathway (Jia et al., 2020)
It is surmised that this fasting pattern results in energy reserves being accessed without leading to micronutrient deficiencies due to replenishment after sunset
Medical Guidance: Who Should Consider Duration When Dosing Patients with significant renal impairment, hepatic disease, advanced age, or those taking medications that inhibit GLP-1 metabolism should discuss duration implications with their provider before starting therapy
*May have a laxative effect if consumed in excess